Barclays’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Barclays’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-83,979	Closed	-$1.64M	–	5545
2022 Q4	$1.64M	Buy	83,979 +1,234	+1%	+$24.8K	﹤0.01%	2396
2022 Q3	$1.73M	Buy	82,745 +2,217	+3%	+$63.3K	﹤0.01%	1850
2022 Q2	$2.58M	Buy	+80,528	New	+$3.04M	﹤0.01%	1673

Barclays's ELAT Position: Q1 2023 in Review

Barclays sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 83,979 shares — an estimated $1.64M sold.

Barclays first reported a position in ELAT in Q2 2022 and held it in 3 quarters. The position peaked at $2.58M in Q2 2022. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

Barclays reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
Barclays sold 83,979 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $1.64M.
Barclays first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q2 2022 and held it in 3 quarters.
Barclays's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $2.58M in Q2 2022.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.